Suchergebnisse - (Subject:"CD8-Positive T-Lymphocytes")

PubPharm (928)

31

High Tumor-Infiltrating Lymphocyte Count Is Associated with Distinct Gene Expression Profile and Longer Patient Survival in Advanced Ovarian Cancer

enthalten in: International journal of molecular sciences | 2023

von Barna, A. | Herold, Z. | Acs, M. | +9

32

Local blockade of tacrolimus promotes T-cell-mediated tumor regression in systemically immunosuppressed hosts

enthalten in: Journal for immunotherapy of cancer | 2023

von Veitch, M. | Beaumont, K. | Pouwer, R. | +8

33

Vinblastine resets tumor-associated macrophages toward M1 phenotype and promotes antitumor immune response

enthalten in: Journal for immunotherapy of cancer | 2023

von Wang, Y. | Wang, Y. | Wang, J. | +3

34

CD5 Expression Dynamically Changes During the Differentiation of Human CD8+ T Cells Predicting Clinical Response to Immunotherapy

enthalten in: Immune network | 2023

von Kim, Y. | Rho, K. | Jeong, S. | +7

35

Inhibition of tumor intrinsic BANF1 activates antitumor immune responses via cGAS-STING and enhances the efficacy of PD-1 blockade

enthalten in: Journal for immunotherapy of cancer | 2023

von Wang, M. | Huang, Y. | Chen, M. | +9

36

Id-neoantigen vaccine induces therapeutic CD8+ T cells against multiple myeloma : H chain-loss escapees cause FLC MM

enthalten in: Journal for immunotherapy of cancer | 2023

von Westhrin, M. | Blazevski, J. | Textor, A. | +10

37

Single-cell sequencing on CD8+ TILs revealed the nature of exhausted T cells recognizing neoantigen and cancer/testis antigen in non-small cell lung cancer

enthalten in: Journal for immunotherapy of cancer | 2023

von Komuro, H. | Shinohara, S. | Fukushima, Y. | +27

38

Saponin-based adjuvants enhance antigen cross-presentation in human CD11c+ CD1c+ CD5- CD163+ conventional type 2 dendritic cells

enthalten in: Journal for immunotherapy of cancer | 2023

von Ho, N. | Huis In 't Veld, L. | van Eck van der Sluijs, J. | +8

39

CLN-978, a novel half-life extended CD19/CD3/HSA-specific T cell-engaging antibody construct with potent activity against B-cell malignancies with low CD19 expression

enthalten in: Journal for immunotherapy of cancer | 2023

von Meetze, K. | Mehta, N. | Li, B. | +2

ErratumIn: J Immunother Cancer. 2023 Dec 14;11(12):. - PMID 38101863

40

KLF12 overcomes anti-PD-1 resistance by reducing galectin-1 in cancer cells

enthalten in: Journal for immunotherapy of cancer | 2023

von Zheng, Y. | Zhang, H. | Xiao, C. | +5